Innoviva Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Innoviva Inc's ROI in the third quarter of 2026?
Innoviva Inc achieved a return on average invested assets (ROI) of 12.3 % in its third quarter of 2026, which is below Innoviva Inc's average return on investment, which stands at 17.26%.

ROI fell compared to the second quarter of 2026, despite the net income growth of % from the second quarter of 2026.

Within the Healthcare sector 43 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 61 to 125.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	45.97 %	56.17 %	37.14 %	14.17 %	-0.3 %
Y / Y Net Income Change TTM	51.9 %	824.31 %	-	1158.6 %	10398.27 %
Investment (TTM) in Millions	1,488	1,656	1,658	1,488	1,323
Return On Investment (TTM)	12.3 %	23.33 %	36.71 %	22.62 %	11.82 %
INVA's Overall Ranking	# 125	# 61	# 172	# 429	#
Seq. Investment Change TTM	2.69 %	11.44 %	14.61 %	11.3 %	9.86 %
Seq. Net Income Change TTM	-45.85 %	-29.17 %	85.99 %	112.94 %	229.49 %
Net Income (TTM) in Millions	193	357	504	271	127

INVA Company Profile >> Back to INVA Roi Comparisons >> See Annual INVA Return On Investment

Return On Investment INVA's Ranking
Within:	No.
Industry	# 21
Sector	# 44
Overall	# 125

Return On Investment Statistics
High	Average	Low
113.51 %	17.26 %	-34.45 %
(Dec 31 2018)		(Mar 31 2013)

Financial Statements
Innoviva Inc's III. Quarter Investments	$ 1,488 Millions	INVA's Balance sheet
Innoviva Inc's III. Quarter Income	$ -74 Millions	Quarterly INVA's Income Statement
INVA's Income by Division		See INVA's Income by Division

INVA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	1,488	1,001	1,122	1,010	1,032
Y / Y Investment Growth	48.65 %	-10.79 %	11.07 %	-2.11 %	-2.79 %
Net Income in Millions	271	23	180	220	369
Y / Y Net Income Growth	1059.22 %	-86.98 %	-18.41 %	-40.28 %	25.53 %
Annual Return On Investment	18.23 %	2.34 %	16.02 %	21.81 %	35.75 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 18.23 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INVA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INVA's Competitors
Subscribers only: Roi for Innoviva Inc's Suppliers
Subscribers only: Return On Investment for INVA's Customers

Other Ratios
INVA's Roa	INVA's Inventory Turnover Ratio	INVA's Growth Rates	INVA's Dividend Statistics
	INVA's Profitability Ratios	INVA's Asset Turnover Ratio	INVA's Dividend Growth
INVA's Roe	INVA's Valuation Ratios	INVA's Financial Strength Ratios	INVA's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Eli Lilly And Company	32.00 %
Caredx Inc	30.65 %
Zevra Therapeutics Inc	29.88 %
Acadia Pharmaceuticals Inc	26.89 %
Standard Biotools Inc	23.91 %
Iradimed Corporation	22.98 %
Corcept Therapeutics Inc	22.08 %
Resmed Inc	21.10 %
Alector Inc	20.83 %
Chemed Corporation	20.46 %
Halozyme Therapeutics Inc	19.64 %
Pro dex Inc	19.11 %
Dexcom Inc	18.92 %
Illumina Inc	18.74 %
Denali Therapeutics Inc	17.88 %
West Pharmaceutical Services Inc	17.65 %
Healthcare Services Group Inc	17.18 %
Neurocrine Biosciences Inc	16.94 %
Krystal Biotech Inc	16.91 %
Vertex Pharmaceuticals Inc	16.63 %
Intuitive Surgical Inc	16.30 %
Hca Healthcare Inc	15.54 %
Kiniksa Pharmaceuticals International Plc	15.45 %
Amgen Inc	13.64 %
Carlisle Companies Incorporated	13.64 %
Bristol myers Squibb Company	13.59 %
3m Company	13.24 %
Beone Medicines Ltd	13.17 %
Regeneron Pharmaceuticals Inc	13.00 %
Abbvie Inc	12.87 %

Date modified: 2026-11-08T13:39:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.